PellePharm
is a pharmaceutical company that researches and develops novel therapeutics for the treatment of dermatological diseases... Read morePellePharm
is a pharmaceutical company that researches and develops novel therapeutics for the treatment of dermatological diseases... Read more
News
Jan 27, 2023
Endpoints News
PellePharm: BridgeBio company sells off rare disease candidate to Galderma partner
Jan 27, 2023
MarketScreener
PellePharm: Sol Gel Technologies : Patidegib Acquisition Call
Oct 29, 2020
MarketScreener
PellePharm: PellePharm to Highlight Clinical Programs at the 29th Congress of the European Academy of Dermatology and Venereology
Jan 08, 2020
MarketScreener
PellePharm: BridgeBio Pharma : PellePharm Initiates Phase 2 Clinical Trial of Patidegib Topical Gel for People With High Frequency Basal Cell Carcinoma
Dec 02, 2019
BioPortfolio
PellePharm: PellePharm Completes Enrollment of Pivotal Phase 3 Clinical Trial of Patidegib Topical Gel in Patients with Gorlin Syndrome
Apr 01, 2019
Business Wire
Press Release: PellePharm : PellePharm Initiates Pivotal Phase 3 Clinical Trial of Patidegib Topical Gel in Patients with Gorlin Syndrome
Feb 01, 2019
Contract Pharma
PellePharm: Phyton Biotech Partners with PellePharm
Nov 21, 2018
The Pharma Letter
PellePharm: PellePharm partners with LEO Pharma to advance therapies for rare skin diseases
Nov 21, 2018
PharmiWeb
PellePharm: PellePharm to Present at Piper Jaffray Healthcare Conference
Nov 20, 2018
The Business Journals
PellePharm: With 'breakthrough' skin cancer drug, small S.F. drug maker lands European cash
PellePharm Competitors
1
2
3
4
5
6
7
8
9
10